REFERENCES

1. Bosetti C, Bertuccio P, Malvezzi M, Levi F, Chatenoud L, et al. Cancer mortality in Europe, 2005-2009, and an overview of trends since 1980. Ann Oncol 2013;24:2657-71.

2. Chuang SC, La Vecchia C, Boffetta P. Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection. Cancer Lett 2009;286:9-14.

3. Trichopoulos D, Bamia C, Lagiou P, Fedirko V, Trepo E, et al. Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested casecontrol study. J Natl Cancer Inst 2011;103:1686-95.

4. Barros RK, Cotrim HP, Daltro C, Alves E, de Freitas LRA, et al. Nonalcoholic steatohepatitis in morbid obese patients: coffee consumption vs. disease severity. Ann Hepatol 2016;15:350-5.

5. Wierzejska R. Coffee consumption vs. cancer risk - a review of scientific data. Rocz Panstw Zakl Hig 2015;66:293-8.

6. Yu X, Bao Z, Zou J, Dong J. Coffee consumption and risk of cancers: a meta-analysis of cohort studies. BMC Cancer 2011;11:96.

7. Ruhl CE, Everhart JE. Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States. Gastroenterology 2005;128:24-32.

8. Bohn SK, Blomhoff R, Paur I. Coffee and cancer risk, epidemiological evidence, and molecular mechanisms. Mol Nutr Food Res 2014;58:915-30.

9. Hösel M, Quasdorff M, Wiegmann K, Webb D, Zedler U, et al. Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection. Hepatology 2009;50:1773-82.

10. Takaki A. Control of oxidative stress in hepatocellular carcinoma: helpful or harmful? World J Hepatol 2015;7:968.

11. Murphy MP. How mitochondria produce reactive oxygen species. Biochem J 2008;417:1-13.

12. Degli Esposti D, Hamelin J, Bosselut N, Saffroy R, Sebagh M, et al. Mitochondrial roles and cytoprotection in chronic liver injury. Biochem Res Int 2012;2012:387626.

13. Pedro JMB, Kroemer G, Filigheddu N, Galluzzi L, Porporato PE. Mitochondrial metabolism and cancer. Cell Res 2017;28:265-80.

14. Dhanasekaran R, Bandoh S, Roberts LR. Molecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advances. F1000Res 2016;5:879.

15. Okano J, Nagahara T, Matsumoto K, Murawaki Y. Caffeine inhibits the proliferation of liver cancer cells and activates the MEK/ERK/EGFR signalling pathway. Basic Clin Pharmacol Toxicol 2008;102:543-51.

16. Cavin C, Holzhaeuser D, Scharf G, Huber WW, Schilter B. Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity. Food Chem Toxicol 2002;40:1155-63.

17. Huber WW, Scharf G, Rossmanith W, Prustomersky S, Grasl-Kraupp B, et al. The coffee components kahweol and cafestol induce gamma-glutamylcysteine synthetase, the rate limiting enzyme of chemoprotective glutathione synthesis, in several organs of the rat. Arch Toxicol 2002;75:685-94.

18. Tanaka K, Hara M, Sakamoto T, Higaki Y, Mizuta T, et al. Inverse association between coffee drinking and the risk of hepatocellular carcinoma: a case-control study in Japan. Cancer Sci 2007;98:214-8.

19. Hu G, Tuomilehto J, Pukkala E, Hakulinen T, Antikainen R, et al. Joint effects of coffee consumption and serum gamma-glutamyltransferase on the risk of liver cancer. Hepatology 2008;48:129-36.

20. Cano-Marquina A, Tarín JJ, Cano A. The impact of coffee on health. Maturitas 2013;75:7-21.

21. Inoue M, Yoshimi I, Sobue T, Tsugane S; JPHC Study Group. Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan. J Natl Cancer Inst 2005;97:293-300.

22. Johnson S, Wang R. Coffee consumption and reduced risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study. Cancer Causes Control 2012;22:503-10.

23. Bamia C, Lagiou P, Jenab M, Trichopoulou A, Fedirko V, et al. Coffee, tea and decaffeinated coffee in relation to hepatocellular carcinoma in a European population: multicentre, prospective cohort study. Int J Cancer 2015;136:1899-908.

24. Aleksandrova K, Bamia C, Drogan D, Lagiou P, Trichopoulou A, et al. The association of coffee intake with liver cancer risk is mediated by biomarkers of inflammation and hepatocellular injury: data from the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr 2015;102:1498-508.

25. Kurozawa Y, Ogimoto I, Shibata A, Nose T, Yoshimura T, et al. Coffee and risk of death from hepatocellular carcinoma in a large cohort study in Japan. Br J Cancer 2005;93:607-10.

26. Kondili LA, Lala A, Gunson B, Hubscher S, Olliff S, et al. Primary hepatocellular cancer in the explanted liver: outcome of transplantation and risk factors for HCC recurrence. Eur J Surg Oncol 2007;33:868-73.

27. Eini H, Frishman V, Yulzari R, Kachko L, Lewis EC, et al. Caffeine promotes anti-tumor immune response during tumor initiation: involvement of the adenosine A2A receptor. Biochem Pharmacol 2015;98:110-8.